{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:40:26Z","timestamp":1792665626123,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:00:00Z","timestamp":1789257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20181243"],"award-info":[{"award-number":["BK20181243"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007540","name":"Jiangsu Provincial Agricultural Science and Technology Innovation Fund","doi-asserted-by":"publisher","award":["CX(24)2001"],"award-info":[{"award-number":["CX(24)2001"]}],"id":[{"id":"10.13039\/100007540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.virusres.2026.199801","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:56:23Z","timestamp":1789397783000},"page":"199801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants"],"prefix":"10.1016","volume":"373","author":[{"given":"Ya-ting","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-zhu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-sai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Osterrieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2026.199801_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2023.101736","article-title":"Adjuvant effects of novel water\/oil emulsion formulations on immune responses against infectious bronchitis (IB) vaccine in mice","volume":"85","author":"Alsakini","year":"2024","journal-title":"Biologicals"},{"issue":"8","key":"10.1016\/j.virusres.2026.199801_bib0002","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3390\/v15081664","article-title":"An oil-based adjuvant improves immune responses induced by canine Adenovirus-vectored vaccine in mice","volume":"15","author":"Broutin","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199801_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133067","article-title":"Structural characterization and adjuvant activity of a water soluble polysaccharide from Poria cocos","volume":"273","author":"Gu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virusres.2026.199801_bib0004","doi-asserted-by":"crossref","unstructured":"Halenova, T., Zlatskiy, I., Syroeshkin, A., Maximova, T., Pleteneva, T., 2020. Deuterium-depleted water as adjuvant therapeutic agent for treatment of diet-induced obesity in rats. 25(1), 23.","DOI":"10.3390\/molecules25010023"},{"key":"10.1016\/j.virusres.2026.199801_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845680","article-title":"Enhanced immune responses in mice induced by the c-di-GMP adjuvanted inactivated vaccine for Pseudorabies virus","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.virusres.2026.199801_bib0006","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1080\/21645515.2021.1906601","article-title":"Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China","volume":"17","author":"Hu","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virusres.2026.199801_bib0007","doi-asserted-by":"crossref","unstructured":"Hussein, H.A., Ismail, N.M., El-Deeb, A.H., Emara, M.M., Tawfik, H.I., Wanis, N.A.J.I.J.O.P.S., 2018. IMS 1313-nanoparticle mucosal vaccine enhances immunity against avian influenza and Newcastle disease viruses. 17, 167\u2013174.","DOI":"10.3923\/ijps.2018.167.174"},{"issue":"2","key":"10.1016\/j.virusres.2026.199801_bib0008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.vetpar.2011.05.019","article-title":"Montanide\u2122 IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina","volume":"182","author":"Jang","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.virusres.2026.199801_bib0009","doi-asserted-by":"crossref","unstructured":"Lamote, J.A.S., Glorieux, S., Nauwynck, H.J., Favoreel, H.W., 2016. The US3 protein of Pseudorabies Virus drives viral passage across the basement membrane in porcine Respiratory mucosa explants. 90(23), 10945\u201310950.","DOI":"10.1128\/JVI.01577-16"},{"issue":"4","key":"10.1016\/j.virusres.2026.199801_bib0010","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2024.03.015","article-title":"Vaccine adjuvants: tailoring innate recognition to send the right message","volume":"57","author":"Lavelle","year":"2024","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.virusres.2026.199801_bib0011","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ac56f3","article-title":"Mg\/Al-LDH as a nano-adjuvant for pertussis vaccine: a evaluation compared with aluminum hydroxide adjuvant","volume":"33","author":"Li","year":"2022","journal-title":"Nanotechnology"},{"issue":"7","key":"10.1016\/j.virusres.2026.199801_bib0012","first-page":"2686","article-title":"Effects of different mucosal adjuvants on immune responses induced by porcine deltacoronavirus in mice","volume":"62","author":"Li","year":"2022","journal-title":"Acta Microbiol. Sin."},{"issue":"1","key":"10.1016\/j.virusres.2026.199801_bib0013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41541-025-01251-5","article-title":"A self-amplifying mRNA vaccine expressing PRV gD induces robust immunity against virulent mutants","volume":"10","author":"Ling","year":"2025","journal-title":"Npj Vac."},{"issue":"4","key":"10.1016\/j.virusres.2026.199801_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0021-9975(08)80310-6","article-title":"Pneumonia in pigs infected with pseudorabies virus and haemophilus parasuis serovar 4","volume":"110","author":"Narita","year":"1994","journal-title":"J. Comp. Pathol."},{"issue":"4","key":"10.1016\/j.virusres.2026.199801_bib0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-1135(94)00103-4","article-title":"Cell-free and cell-associated viremia in pigs after oronasal infection with Aujeszky's disease virus","volume":"43","author":"Nauwynck","year":"1995","journal-title":"Vet. Microbiol."},{"issue":"5","key":"10.1016\/j.virusres.2026.199801_bib0016","first-page":"1083","article-title":"Screening of immune adjuvants for inactivated Erysipelothrix rhusiopathiae vaccine","volume":"51","author":"Pei","year":"2020","journal-title":"Acta Vet. Zootech. Sin."},{"issue":"5","key":"10.1016\/j.virusres.2026.199801_bib0017","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virusres.2026.199801_bib0019","doi-asserted-by":"crossref","unstructured":"Saleemi, M.A., Zhang, Y., Zhang, G., 2024. Current progress in the science of novel adjuvant nano-vaccine-induced protective immune responses. 13(6), 441.","DOI":"10.3390\/pathogens13060441"},{"issue":"4","key":"10.1016\/j.virusres.2026.199801_bib0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1586\/erv.11.21","article-title":"Trends in vaccine adjuvants","volume":"10","author":"Schijns","year":"2011","journal-title":"Expert Rev. Vac."},{"key":"10.1016\/j.virusres.2026.199801_bib0021","article-title":"Oil-based emulsion vaccine adjuvants","volume":"106","author":"Schijns","year":"2014","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.virusres.2026.199801_bib0022","doi-asserted-by":"crossref","unstructured":"Shan, P., Wang, Z., Li, J., Wei, D., Zhang, Z., Hao, S., Hou, Y., Wang, Y., Li, S., Wang, X., Xu, J., 2022. A new nano adjuvant of PF3 used for an enhanced Hepatitis B vaccine. Volume 10.","DOI":"10.3389\/fbioe.2022.903424"},{"key":"10.1016\/j.virusres.2026.199801_bib0023","doi-asserted-by":"crossref","unstructured":"Stewart-Tull, D.E.S.J.M.I.M.M., 1996. The use of adjuvants in experimental vaccines: II. Water-in-oil emulsions: freund's complete and lncomplete adjuvants. 4, 141\u2013145.","DOI":"10.1385\/0-89603-334-1:141"},{"key":"10.1016\/j.virusres.2026.199801_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121385","article-title":"A solid-in-oil-in-water emulsion: an adjuvant-based immune-carrier enhances vaccine effect","volume":"282","author":"Tahara","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.virusres.2026.199801_bib0025","doi-asserted-by":"crossref","unstructured":"Takahashi, H., Yoshikawa, Y., Kai, C., Yamanouchi, K.J.T.J.O.V.M.S., 1993. Mechanism of pruritus and peracute death in mice induced by pseudorabies virus (PRV) infection. 55 6, 913\u2013920.","DOI":"10.1292\/jvms.55.913"},{"issue":"4","key":"10.1016\/j.virusres.2026.199801_bib0026","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12250-020-00340-0","article-title":"Current status and challenge of pseudorabies virus infection in China","volume":"36","author":"Tan","year":"2021","journal-title":"Virol. Sin."},{"issue":"2","key":"10.1016\/j.virusres.2026.199801_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02058-16","article-title":"Age-dependent differences in pseudorabies virus neuropathogenesis and associated cytokine expression","volume":"91","author":"Verpoest","year":"2017","journal-title":"J. Virol."},{"issue":"27","key":"10.1016\/j.virusres.2026.199801_bib0028","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.vaccine.2014.04.035","article-title":"A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199801_bib0029","article-title":"Preparation method and application of a saponin-containing lipid nanoparticle","author":"Wang","year":"2023","journal-title":"Chin. Pat. CN."},{"issue":"8","key":"10.1016\/j.virusres.2026.199801_bib0030","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1080\/21645515.2021.1880200","article-title":"Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: a post-marketing, parallel control clinical trial","volume":"17","author":"Zhang","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.virusres.2026.199801_bib0031","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.virusres.2026.199801_bib0032","series-title":"Screening of Immune Adjuvants for Trivalent Inactivated Streptococcus suis Vaccine","author":"Zhao","year":"2021"},{"issue":"8","key":"10.1016\/j.virusres.2026.199801_bib0033","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3390\/v14081638","article-title":"Pseudorabies virus: from pathogenesis to prevention strategies","volume":"14","author":"Zheng","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199801_bib0034","doi-asserted-by":"crossref","unstructured":"Zhou, M., Abid, M., Cao, S., Zhu, S., 2023. Recombinant Pseudorabies virus usage in vaccine development against swine infectious disease. 15(2), 370.","DOI":"10.3390\/v15020370"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:07:02Z","timestamp":1792663622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0168170226001206"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199801","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199801"}}